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PAF episodes were divided into group A (“sudden onset”) and group B (“PAC activity
before onset”). The mean PAF episode durations of both groups were then compared.
Sudden PAF onset was defined as missing PAC activity in the last 10 beats before PAF
initiation.
Results: Group A comprised 145 (54.9 %) PAF episodes. A significantly longer mean
PAF episode duration was found in group A as compared to group B (6.06 ± 42.36 vs.
1.85 ± 6.72 hours, p < 0.01).
Conclusion: 1. In our study group more than half of the PAF episodes were initiated
without any PAC activity in the last 10 beats before onset. 2. Arrhythmia episodes with
sudden PAF onset were associated with a prolonged PAF episode duration as compared
to PAF episodes with prevalent pre-onset PAC activity. 3. The combination of missing
PAC activity and long PAF episode duration may reflect a higher atrial “substrate factor”
facilitating PAF induction and maintenance. The efficacy of preventive pacing algorithms
might therefore be limited in patients with predominantly sudden onset of PAF.
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1052-207 Left Atrial Flutter Post Pulmonary Vein Isolation: Draw a 
Line or Reisolation of the Recovered Pulmonary Vein 
Ostium?
Jennifer E. Cummings, Mandeep Bhargava, J. David Burkhardt, Yaariv Khaykin, George 
Joseph, Ahmad Abdul-Karim, Atul Verma, Walid Saliba, Robert Schweikert, David O. 
Martin, Nassir Marrouche, Andrea Natale, The Cleveland Clinic Foundation, Cleveland, 
OH
Background:The incidence of left atrial flutter (LAFL) post pulmonary vein isolation (PVI)
for treatment of atrial fibrillation (AF) has been reported to vary between 2 and 8%. We
report our experience with this arrhythmia.
Methods: 613 patients presented for PVI for treatment of symptomatic AF. All PVs and
when possible, the superior vena cava (SCV), were ablated in all patients. Patients were
followed post-ablation for incidence of recurrent arrhythmias and brought back to the
electrophysiology lab for re-evaluation.
Results: After a mean follow up of 491±290 days, 15 patients developed recurrence of
LAFL. Out of 24 flutter circuits identified in these patients, 5 could not be mapped. The
remaining 19 circuits were defined using the CARTO 3D mapping system. Of these 19
circuits, 10 circuits were defined to be between the mitral annulus and a posterior wall
scar, 5 were between two posterior wall scars, 3 were around the left PV, and 1 rotated
around the septum primum. In all 15 patients, recovery of 2 ± 2 PV ostial conduction was
detected. Re-isolation of the recovered sites was subsequently performed. Additionally, a
flutter line was needed to terminate a mitral annulus circuit and a circuit between 2 poste-
rior wall scars. After a mean follow-up of 340±90 days, only one patient experienced
recurrence of LAFL.
Conclusion: In patients with recurrent LAFL post PVI, re-isolation of recovered PV ostia
appears to be sufficient in curing the majority of patients presenting with LAFL following
PVI treatment of AF.
1052-208 Left Atrial Flutter Following Circumferential Pulmonary 
Vein Ablation for the Treatment of Atrial Fibrillation
Jun Dong, Bernhard Zrenner, Jürgen Schreieck, Isabel Deisenhofer, Michael Schneider, 
Ildiko Dobran, Martin Karch, Andreas Plewan, Christian von Bary, Claus Schmitt, 
German Heart Center Munich, Munich, Germany
Background: Circumferential pulmonary vein ablation (CPVA) has emerged as a curative
therapy for atrial fibrillation (AF). Linear ablation lesions deployed in the left atrium (LA)
may serve as substrates supporting left atrial flutter (LAFL). This study sought to investi-
gate the incidence and substrates of LAFL following CPVA.
Methods: Fifty-one consecutive pts (57 +/- 9 yrs, 17 F) with paroxysmal (n = 45) or per-
sistent (n = 6) AF were included. CPVA was performed by delivering radiofrequency (RF)
lesions around the ostia of pulmonary veins (PV) plus a linear lesion bridging the ostium
of left inferior PV to the mitrial annulus (MA) under 3D electroanatomic (Carto) guidance.
Periodic 7-day Holter monitoring was conducted after ablation to screen the occurrence
of LAFL and recurrence of AF. Repeated electroanatomic mapping and RF ablation pro-
cedure was advised if sustained LAFL was documented.
Results: Eleven pts (22%) had documented sustained LAFL during the index procedure
or during follow up. Of those, electroanatomic and entrainment mapping were performed
in 5 pts to delineate reentry circuits. Among 14 LAFLs (2.8 per pt, cycle length 190 to
305ms) encountered in the procedures, electroanatomic mapping was completed during
9 LAFLs. Carto activation map showed: 3 LAFLs rotated around a functional line of block
on the LA posterior wall created by prior linear lesion; 2 LAFLs were dual loop reentry
rotating around 2 adjacent functional lines of block on LA posterior wall after linear abla-
tions, respectively, and used one gap in between as their common pathway; 2 LAFLs
rotating around right PVs were constrained by MA and a line of block created by prior lin-
ear ablation; 1 LAFL rotated around a line of block through 2 gaps at the prior linear
lesion encircling the left upper PV; 1 LAFL was a peri-MA reentry. After a median of 8
(range 1-16) months follow-up, 5/11 (46%) pts had AF recurrence, 4/11(36%) were in
sinus rhythm, 2/11 (18%) in persistent LAFL.
Conclusions: LAFL occurs in 22% of pts after CPVA. Discrete functional or fixed lines of
block with single or multiple gaps, created by prior linear ablation lesions, serve as the
most common substrates supporting LAFLs. LAFL may contribute to the recurrence of
AF after CPVA.
1052-219 Early Changes in Pulmonary Vein Activation Predict 
Effectiveness During Pulmonary Vein Isolation Using a 
Novel Curvilinear Cryoablation Catheter
Tom Wong, Vias Markides, Nicholas S. Peters, D. Wyn Davies, St. Mary's Hospital and 
Imperial College, London, United Kingdom
Background
Pulmonary vein (PV) isolation by cryoablation can be time-consuming, predominantly
due to the long duration of each cryo-application but has safety advantages in avoiding
PV stenosis and local thrombus formation. We hypothesized that the likely effectiveness
of each cryo-application can be predicted by early changes in PV activation during cryo-
delivery. This may consequently shorten the procedural cryo-application time that was
needed for isolation.
Methods
Using a novel 7F steerable curvilinear tipped cryoablation catheter (Artic CirclerTM), we
targeted 32 PVs (diameter 19±5mm) in 17pts (12M, age 52±12yrs) with drug refractory
paroxysmal atrial fibrillation. The cryoablation catheter was placed at the ostium of each
targeted vein, proximal to a circumferential mapping catheter (Lasso TM). Cryoablative
lesions were created at <-80ºC for <4min. PV isolation was defined as either the elimina-
tion of PV electrograms or their dissociation from left atrial (LA) electrograms. An effec-
tive application was defined as one causing a significant change in PV activation.
Results
Twenty-five (78%) PVs were successfully isolated, 16 using the circular cryoablation
catheter alone, and 9 after additional cryoablation with a 6mm-tipped catheter. Of 371
(12±8 per PV) applications delivered using the circular catheter, 107 (29%) were termi-
nated within 60s due to suboptimal catheter position. The remaining 265 applications
(71%) were continued for >60s (mean 200±64s), of which 92 (35%) were effective. To
detect a possible cumulative effect, applications for each PV were divided into tertiles.
Effective applications were evenly distributed across these (32, 30 and 30 for the 1st,
2nd, and last tertile, respectively), so that the index of effectiveness was independent of
total energy delivered. All but one effective application caused a >10% prolongation of
LA-PV conduction time or a significant change in PV morphology within the first 40
(17±13) sec of the delivery.
Conclusion
Effective application using a circular cryoablation catheter can be predicted by early
changes in PV activation. This may avoid prolonged applications at ineffective sites and
shorten procedure time.
1052-220 Safety and Efficacy of Catheter Ablation of Atrial 
Fibrillation Using an Irrigated-Tip Ablation Catheter
Chandrasekhar R. Vasamreddy, Vinod Jayam, Lars Lickfett, David Bradley, Khurram 
Nasir, Zayd Eldadah, Timm Dickfeld, Kevin Donahue, Ronald Berger, Hugh Calkins, 
Johns Hopkins School of Medicine, Baltimore, MD
Introduction: The purpose of the study is to report the safety and efficacy of catheter
ablation of atrial fibrillation (AF) using an irrigated- tip ablation catheter.
ethods: Seventy-five consecutive patients (51 men; age 54 + 13 years) with symptomatic
drug refractory paroxysmal (42 patients), persistent (21 patients) or permanent (12
patients) AF underwent catheter ablation of AF using an irrigated-tip ablation catheter
and a standard ablation strategy, which involved electrical isolation of all pulmomary
veins (PVs) and creation of a cavotricuspid linear lesion.
Results: At 10.5+7.5 months of follow-up following a single (n= 75) or redo ablation pro-
cedure (n=11), 39 of the 75 patients were free of AF (52%), 10 were improved (13%), and
26 had experienced no benefit from the ablation procedure (35%). The most significant
complications were two episodes of pericardial tamponade, mitral valve injury in one
patient, two strokes, and complete but asymptomatic PV stenosis in one patient. A Cox
proportional hazards multivariate regression analysis identified the presence of persis-
tent AF, permanent AF and age more than 50 years prior to the ablation were the only
independent predictors of AF recurrence after the first PV isolation procedure.
Conclusions: Catheter ablation of AF using a strategy involving isolation of all PVs, the
creation of a linear lesion in the cavotricuspid isthmus, using cooled RF energy is associ-
ated with moderate efficacy and an important risk of complications. The best results of
this procedure are achieved in the subset of patients who are less than 50 years of age
and have only paroxysmal AF. It is likely that more aggressive ablation strategy that
involve more extensive and circumferential ablation lesions will be needed in patients
over 50 years with persistent or permanenet AF to achieve higher success rate.
1052-221 Accurate Identification of Pulmonary Vein Ostia With 
Real-Time Impedance Measurements
Peter Cheung, Burr W. Hall, Aman Chugh, Kamala Tamirisa, Jihn Han, Kristina Lemola, 
Frank Pelosi, Jr., Fred Morady, Hakan Oral, University of Michigan, Ann Arbor, MI
Background: During radiofrequency ablation to encircle or isolate the pulmonary veins
(PV), accurate identification of the ostia is critical to prevent PV stenosis. Impedance may
be higher within a PV than at its ostium. The purpose of this study was to determine
whether monitoring of real-time impedance facilitates identification of the PV ostia.
Methods and Results: In 26 consecutive patients (mean age= 54 ± 11 years) who
underwent a left atrial ablation procedure, the 3-D geometry of the left atrium, the PVs,
and their ostia were reconstructed using an electroanatomical mapping system. The PV
ostia were identified based on venography, changes in electrogram morphology, and
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manual and fluoroscopic visual feedback as the catheter was withdrawn from the PV into
the left atrium. Real-time impedance was measured at the ostium, inside the PV at
approximately 1 and 3 cms from the ostium, in the left atrial appendage, and at the poste-
rior left atrial wall. There was an impedance gradient from the distal PV (127 ± 30 Ω) to
the proximal PV (108 ± 15 Ω) to the ostium (98 ± 11 Ω) in each PV (p<0.01). There were
no significant impedance difference between the ostial and left atrial sites. Impedance
was higher in the distal and proximal right inferior PV than in the other PVs (p<0.01).
Ostial impedance was similar among all PVs.
Conclusions: There is a significant impedance gradient from the left atrium to the distal
PV. Continuous monitoring of a rise in impedance during ostial ablation for PV isolation
may prevent inadvertent applications of RF energy within the PV and may minimize the
risk of PV stenosis.
1052-222 Thromboembolic Events in Patients Undergoing Atrial 
Fibrillation Ablation-Incidence, Timing, and Predictors
Mark E. Vanderhoff, Erica S. Zado, Edward P. Gerstenfeld, Sanjay Dixit, Hemal Nayak, 
Andrea M. Russo, David J. Callans, Francis E. Marchlinski, University of Pennsylvania 
Health System, Philadelphia, PA
BACKGROUND: Thromboembolic stroke (TES) remains a serious complication of pul-
monary vein (PV) isolation for atrial fibrillation (AF). We sought to determine the inci-
dence and risk factors associated with TES in a consecutive series of pts undergoing AF
ablation. METHODS: Between December 1999 and August 2003, 400 patients under-
went PV isolation. Lasso mapping catheter (LMC) was used to define PV ostium (os) and
RFA lesions using a 4 mm Navistar catheter (40 W, 52°C, 90 sec) were created proximal
to LMC poles showing earliest PV potentials (entry). Heparin was infused to maintain
activated clotting time (ACT) at >250 seconds and intracardiac echocardiographic moni-
toring (ACUNAVTM) was performed.
RESULTS: Four patients (1.0%; 3 males; age: 53±2 years) developed TES (sudden
onset new neurologic deficit). All TES events occurred in initial 6 hours after completion
of procedure following reversal of ACT with protamine bolus (mean dose 15±5 mg).
Three patients had complete neurologic recovery (two patients required tPA). Compari-
son between pts manifesting TES and those that did not is shown in the table. No patient
developed TES during the actual ablation procedure.
CONCLUSION: TES is infrequently observed in pts undergoing AF ablation and appears
most common in the early post ablation period. Pts with prior history of TES events are at
highest risk, 3 of 15 (20%). These data have important implications regarding patient
selection, counseling, and management prior to and following AF ablation procedure.
* p < 0.001
1052-223 Does Catheter Ablation of Atrial Fibrillation Alter 
Intrinsic Left Atrial Mechanical Function?
David Schwartzman, Raveen Bazaz, Doug Hettrick, University of Pittsburgh, Pittsburgh, 
PA, Medtronic, Inc., Minneapolis, MN
Background: The impact of left atrial (LA) catheter ablation on intrinsic global mechani-
cal function of the chamber is unclear. Methods: Seventeen patients (median data: age
56 yrs; LA 42 mm; EF 54%) underwent LA ablation in an effort to suppress atrial fibrilla-
tion. Radiofrequency energy, applied in the LA body, was targeted so as to "encircle" both
left and right pulmonary venous vestibules. In each patient this yielded ablation or electri-
cal isolation of the subtended myocardium. In each patient, instantaneous LA pressure
and volume (conductance) were measured simultaneously. Measurements were made
using a catheter placed into the LA body. Data was acquired immediately prior to and
after ablation. Analysis utilized multiple indices of LA pump and reservoir functions.
Results (table shows mean + standard deviation): 
Conclusions: Despite a large volume of ablated/isolated myocardium, ablation did not
significantly alter intrinsic global LA mechanical function. A significant impact on regional
function cannot be excluded.
1052-224 Pre-Existent Left Atrial Scarring in Patients Undergoing 
Pulmonary Vein Isolation: An Independent Predictor of 
Procedural Failure
Nassir Marrouche, Jennifer E. Cummings, Mandeep Bhargava, J. David Burkhardt, 
George Joseph, Yaariv Khaykin, Atul Verma, Ahmad Abdul-Karim, Walid Saliba, Robert 
Schweikert, Andrea Natale, The Cleveland Clinic Foundation, Cleveland, OH
Background:The goal of this study was to assess the impact of pre-existent left atrial
scarring on long-term procedural outcomes in patients undergoing pulmonary vein isola-
tion (PVI) for atrial fibrillation.
Methods: 613 patients presented for PVI for treatment of atrial fibrillation (AF). Prior to
each PVI procedure the left atrium (LA) was mapped using a multipolar Lasso catheter.
LA scar was defined as a voltage < 0.5 mV. Out of 613 patients scarring of the LA wall
was present in 31 patients. All PVs and the SVC were ablated in all study patients.
Results: The table below describes the outcomes in the 2 study groups.
Conclusion: Pre-existent left atrial scarring in patients undergoing pulmonary vein isola-
tion for treatment of symptomatic atrial fibrillation predicts long-term procedural failure. 
1052-225 Morphological Features of Marshall Ligament Tissue 
and Interatrial Septum in Patients With Repeated 
Pulmonary Vein Isolation: An Intracardiac 
Echocardiographic Imaging Study
Jian-Fang Ren, Francis E. Marchlinski, David J. Callans, University of Pennsylvania, 
Philadelphia, PA
Background: Morphology of the ligament of Marshall (LOM) and interatrial septum (IAS)
may be important features related to a successful isolation of left and right pulmonary
vein (PV) respectively. The aim of this study was to provide AcuNav ultrasound catheter
imaging measurements of LOM and IAS in pts with repeat radiofrequency (RF) ablation
for AF. Methods and Results: In 517 pts undergoing PV ostial isolation using 4 mm elec-
trode and RF (up to 40W, 52°C, 90sec), 76 (14.7%)(age 57±9 yrs) were required to
repeat (twice, n=8; triple and 4 times, one each) PV ablation for AF. The thickness of
LOM was measured at its cross-sectional view between left upper PV and LA appendage
and the length at an off-axis view between distal coronary sinus and left upper PV
ostium. The IAS thickness was measured at the area 5 mm adjacent to the fossa ovalis.
These measurements were compared to another age-matched 40 pts without repeat RF
for successful PV isolation with 6-month followup.(Table) The thickness of LOM and IAS
was greater in repeat RF pts than those without repeat RF (p<0.05). Higher echogenecity
of thickened LOM and lipomatous hypertrophy of IAS were more frequently observed in
repeat RF pts. Conclusion: Pts with repeat RF PV isolation had more thickening and
echogenecity of LOM and IAS at time of morphologic imaging. This is consistent with
more significant hypertrophy, fibosis or degeneration. Alternative or more effective RF
energy delivery tools may be required in pts with such findings to reduce need for repeat
procedures.
1052-226 Registration of Cardiac Computed Tomography Images 
With Three-Dimensional Electroanatomical Mapping to 
Guide Catheter Manipulation in the Left Atrium: 
Implications for Pulmonary Venous Isolation
Vivek Y. Reddy, Zachary Malchano, Petr Neuzil, Jiri Weichet, Jeremy N. Ruskin, 
Massachusetts General Hospital, Boston, MA, Na Homolce Hospital, Prague, Czech 
Republic
Background: 3D electroanatomical mapping (EAM) systems are frequently employed to
facilitate catheter ablation of atrial fibrillation (AF). Because of the complexity of the
chamber geometry, it is common to obtain preoperative CT/MRI to provide an anatomical
“roadmap” of the left atrium (LA) & pulmonary veins (PVs). In the optimal scenario, the
imaging dataset would be directly integrated and registered (i.e., properly aligned) with
the EAM system so as to guide real-time catheter movement within the LA and to the PV
ostia based on the actual chamber anatomy.
Methods: To determine the feasibility of this image integration paradigm to guide AF
catheter ablation, simulations were performed using a life-size model of the LA, PVs, and
aorta (Ao); the optimal means of achieving accurate registration between EAM data and
imaging data was determined. Based on these simulation results, the image integration
strategy was employed in a series of patients with AF (n=13) undergoing catheter abla-
tion to electrically isolate the PVs. For these patients, CT images of the LA-PVs were pre-
Lesions
(Total #)
Ablation Time (hours) History of prior embolic event
CVA
(n=4)
46
(+/- 8)
3.83
(+/- 1.77)
3
(75%)
No CVA
(n=396)
43
(+/- 8)
2.78
(+/- 1.37)
12
(3%) *
Pre-Ablation Post-Ablation P
    PUMP
Active Emptying Volume (cc) 11 + 18 8 + 7 0.3
A Loop Area (mmHg-cc) 43 + 88 43 + 105 0.9
End-Systolic Elastance Slope (mmHg/cc) 0.5 + 0.3 0.5 + 0.3 0.5
 RESERVOIR
Passive Emptying Volume (cc) 17 + 16 16 + 5 0.6
V Loop Area (mmHg-cc) 23 + 17 33 + 29 0.2
End-Reservoir Elastance  Slope (mmHg/cc) 1.3 + 1.1 1.1 + 0.8 0.8
LA scar No LA scar p value
Patients 31 582
Left atrial size 4.5±0.5 4.2±0.6 0.04
Structural heart disease 52% (16/31) 40% (232/528) 0.04
Ejection fraction 48±8% 54±6% 0.03
Recurrence of AF 46% (14/31) 14% (83/582) <0.0001
Repeat RF No Repeat RF
LOM(mm) Width Length IAS(mm) LOM(mm) Width Length IAS(mm)
Pre- 5.9±1.7 17.4±4.2 10.4±4.0 4.5±1.2 10.2±3.5 6.1±2.4
Post- 9.4±2.0 22.9±3.9
